| Item Type | Name |
|
Concept
|
Radiosurgery
|
|
Academic Article
|
Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer.
|
|
Academic Article
|
Cardiac ?8F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy.
|
|
Academic Article
|
Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy.
|
|
Academic Article
|
Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non?small-cell lung cancer or lung metastases.
|
|
Academic Article
|
Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly.
|
|
Academic Article
|
Pattern of failure following chemoradiation for locally advanced non-small cell lung cancer: potential role for stereotactic body radiotherapy.
|
|
Academic Article
|
Stereotactic body radiation therapy in non-small-cell lung cancer: linking radiobiological modeling and clinical outcome.
|
|
Academic Article
|
Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer.
|
|
Academic Article
|
Critical structure sparing in stereotactic ablative radiotherapy for central lung lesions: helical tomotherapy vs. volumetric modulated arc therapy.
|
|
Academic Article
|
What would be the most appropriate a/? ratio in the setting of stereotactic body radiation therapy for early stage non-small cell lung cancer.
|
|
Academic Article
|
Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.
|
|
Academic Article
|
Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy.
|
|
Academic Article
|
Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer.
|
|
Academic Article
|
American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy.
|
|
Academic Article
|
Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications.
|
|
Academic Article
|
Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.
|
|
Academic Article
|
Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults.
|
|
Academic Article
|
Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults
|
|
Academic Article
|
Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid Tumors.
|
|
Academic Article
|
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells.
|
|
Academic Article
|
Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity.
|
|
Academic Article
|
Phase I Trial: SABR and Ipilimumab-Response.
|
|
Academic Article
|
Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control.
|
|
Academic Article
|
Lung Cancer: Posttreatment Imaging: Radiation Therapy and Imaging Findings.
|
|
Academic Article
|
Prognostic significance of EGFR and KRAS mutations in NSCLC patients with brain metastases treated with radiosurgery?.
|
|
Academic Article
|
Safety of Combined Immunotherapy and Thoracic Radiation Therapy: Analysis of 3 Single-Institutional Phase I/II Trials.
|
|
Academic Article
|
Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer.
|
|
Academic Article
|
Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial.
|
|
Academic Article
|
Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung Cancer.
|
|
Academic Article
|
Commercial Insurance Coverage of Advanced Radiation Therapy Techniques Compared With American Society for Radiation Oncology Model Policies.
|
|
Academic Article
|
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy.
|
|
Academic Article
|
Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses.
|
|
Academic Article
|
Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms.
|
|
Academic Article
|
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses.
|
|
Academic Article
|
Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials.
|
|
Academic Article
|
Definitive Management of Presumed Synchronous Early Stage Non-Small Cell Lung Cancers: Outcomes and Utility of Stereotactic Ablative Radiation Therapy.
|
|
Academic Article
|
Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure.
|
|
Academic Article
|
Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer.
|
|
Academic Article
|
Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy.
|
|
Academic Article
|
Potential Clinical Significance of Overall Targeting Accuracy and Motion Management in the Treatment of Tumors That Move With Respiration: Lessons Learnt From a Quarter Century of Stereotactic Body Radiotherapy From Dose Response Models.
|
|
Academic Article
|
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.
|
|
Academic Article
|
T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer.
|
|
Academic Article
|
A Systematic Review of the Cost-Effectiveness of Stereotactic Radiation Therapy for Cancer Oligometastases.
|
|
Academic Article
|
Local Therapy for Oligoprogressive Disease: A Systematic Review of Prospective Trials.
|
|
Academic Article
|
Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic disease.
|
|
Academic Article
|
Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial.
|